1. Home
  2. FTHM vs COCH Comparison

FTHM vs COCH Comparison

Compare FTHM & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.08

Market Cap

11.4M

Sector

Finance

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$6.70

Market Cap

51.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
COCH
Founded
2010
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Blank Checks
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
51.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
FTHM
COCH
Price
$0.08
$6.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $19.67
AVG Volume (30 Days)
★ 554.9K
33.3K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.71
17.45
EPS
★ N/A
N/A
Revenue
N/A
★ $241,000.00
Revenue This Year
$9.48
N/A
Revenue Next Year
N/A
$15.33
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.11
52 Week Low
$0.08
$4.72
52 Week High
$1.52
$47.70

Technical Indicators

Market Signals
Indicator
FTHM
COCH
Relative Strength Index (RSI) 24.29 19.07
Support Level N/A $4.72
Resistance Level $0.20 $7.46
Average True Range (ATR) 0.02 0.41
MACD 0.00 0.93
Stochastic Oscillator 3.39 20.83

Price Performance

Historical Comparison
FTHM
COCH

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: